1. Home
  2. EVO vs NBHC Comparison

EVO vs NBHC Comparison

Compare EVO & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • NBHC
  • Stock Information
  • Founded
  • EVO 1993
  • NBHC 2009
  • Country
  • EVO Germany
  • NBHC United States
  • Employees
  • EVO N/A
  • NBHC N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • NBHC Major Banks
  • Sector
  • EVO Health Care
  • NBHC Finance
  • Exchange
  • EVO Nasdaq
  • NBHC Nasdaq
  • Market Cap
  • EVO 1.4B
  • NBHC 1.4B
  • IPO Year
  • EVO 2021
  • NBHC 2012
  • Fundamental
  • Price
  • EVO $3.31
  • NBHC $35.77
  • Analyst Decision
  • EVO Strong Buy
  • NBHC Buy
  • Analyst Count
  • EVO 1
  • NBHC 3
  • Target Price
  • EVO $7.00
  • NBHC $44.33
  • AVG Volume (30 Days)
  • EVO 54.5K
  • NBHC 321.8K
  • Earning Date
  • EVO 11-05-2025
  • NBHC 10-21-2025
  • Dividend Yield
  • EVO N/A
  • NBHC 3.46%
  • EPS Growth
  • EVO N/A
  • NBHC N/A
  • EPS
  • EVO N/A
  • NBHC 3.15
  • Revenue
  • EVO $887,396,457.00
  • NBHC $405,867,000.00
  • Revenue This Year
  • EVO N/A
  • NBHC $8.33
  • Revenue Next Year
  • EVO $10.78
  • NBHC $23.76
  • P/E Ratio
  • EVO N/A
  • NBHC $11.39
  • Revenue Growth
  • EVO N/A
  • NBHC 1.03
  • 52 Week Low
  • EVO $2.84
  • NBHC $32.83
  • 52 Week High
  • EVO $5.64
  • NBHC $51.76
  • Technical
  • Relative Strength Index (RSI)
  • EVO 28.61
  • NBHC 41.12
  • Support Level
  • EVO $3.30
  • NBHC $35.06
  • Resistance Level
  • EVO $4.09
  • NBHC $36.68
  • Average True Range (ATR)
  • EVO 0.09
  • NBHC 0.86
  • MACD
  • EVO -0.08
  • NBHC -0.04
  • Stochastic Oscillator
  • EVO 2.06
  • NBHC 24.31

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

Share on Social Networks: